Moderna stock is up 125.51% in 2026, driven by an FDA flu vaccine win, a corporate pivot, and an expanding pipeline. Here's what's moving MRNA. The post This COVID Stock Market Winner Is Making a Comeback, Up 125% Year to Date appeared first on BeInCrypto.